PENUMBRA INC (PEN) Fundamental Analysis & Valuation

NYSE:PEN • US70975L1070

336.18 USD
+1.19 (+0.36%)
At close: Mar 13, 2026
336.18 USD
0 (0%)
After Hours: 3/13/2026, 8:04:00 PM

This PEN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

Taking everything into account, PEN scores 7 out of 10 in our fundamental rating. PEN was compared to 184 industry peers in the Health Care Equipment & Supplies industry. PEN scores excellent points on both the profitability and health parts. This is a solid base for a good stock. PEN is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes PEN very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

8

1. PEN Profitability Analysis

1.1 Basic Checks

  • PEN had positive earnings in the past year.
  • PEN had a positive operating cash flow in the past year.
  • Of the past 5 years PEN 4 years were profitable.
  • PEN had a positive operating cash flow in 4 of the past 5 years.
PEN Yearly Net Income VS EBIT VS OCF VS FCFPEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

1.2 Ratios

  • PEN has a Return On Assets of 9.73%. This is amongst the best in the industry. PEN outperforms 90.22% of its industry peers.
  • PEN's Return On Equity of 12.45% is amongst the best of the industry. PEN outperforms 87.50% of its industry peers.
  • PEN has a better Return On Invested Capital (8.85%) than 86.41% of its industry peers.
  • PEN had an Average Return On Invested Capital over the past 3 years of 6.23%. This is below the industry average of 9.18%.
  • The 3 year average ROIC (6.23%) for PEN is below the current ROIC(8.85%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.73%
ROE 12.45%
ROIC 8.85%
ROA(3y)5.5%
ROA(5y)3.35%
ROE(3y)7.13%
ROE(5y)4.35%
ROIC(3y)6.23%
ROIC(5y)4.07%
PEN Yearly ROA, ROE, ROICPEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10

1.3 Margins

  • PEN has a better Profit Margin (12.66%) than 85.87% of its industry peers.
  • Looking at the Operating Margin, with a value of 13.48%, PEN belongs to the top of the industry, outperforming 80.98% of the companies in the same industry.
  • In the last couple of years the Operating Margin of PEN has grown nicely.
  • Looking at the Gross Margin, with a value of 67.14%, PEN is in the better half of the industry, outperforming 72.28% of the companies in the same industry.
  • In the last couple of years the Gross Margin of PEN has grown nicely.
Industry RankSector Rank
OM 13.48%
PM (TTM) 12.66%
GM 67.14%
OM growth 3Y165.54%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.05%
GM growth 5Y2.16%
PEN Yearly Profit, Operating, Gross MarginsPEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

8

2. PEN Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PEN is destroying value.
  • Compared to 1 year ago, PEN has more shares outstanding
  • The number of shares outstanding for PEN has been increased compared to 5 years ago.
  • PEN has a better debt/assets ratio than last year.
PEN Yearly Shares OutstandingPEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
PEN Yearly Total Debt VS Total AssetsPEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • PEN has an Altman-Z score of 21.74. This indicates that PEN is financially healthy and has little risk of bankruptcy at the moment.
  • PEN's Altman-Z score of 21.74 is amongst the best of the industry. PEN outperforms 96.74% of its industry peers.
  • PEN has a debt to FCF ratio of 0.13. This is a very positive value and a sign of high solvency as it would only need 0.13 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.13, PEN belongs to the top of the industry, outperforming 92.39% of the companies in the same industry.
  • A Debt/Equity ratio of 0.01 indicates that PEN is not too dependend on debt financing.
  • PEN's Debt to Equity ratio of 0.01 is fine compared to the rest of the industry. PEN outperforms 71.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.13
Altman-Z 21.74
ROIC/WACC0.88
WACC10.04%
PEN Yearly LT Debt VS Equity VS FCFPEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 6.64 indicates that PEN has no problem at all paying its short term obligations.
  • The Current ratio of PEN (6.64) is better than 83.70% of its industry peers.
  • A Quick Ratio of 4.29 indicates that PEN has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 4.29, PEN is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.64
Quick Ratio 4.29
PEN Yearly Current Assets VS Current LiabilitesPEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

8

3. PEN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 33.80% over the past year.
  • Measured over the past years, PEN shows a very strong growth in Earnings Per Share. The EPS has been growing by 84.42% on average per year.
  • Looking at the last year, PEN shows a quite strong growth in Revenue. The Revenue has grown by 17.50% in the last year.
  • The Revenue has been growing by 20.16% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)33.8%
EPS 3Y182.68%
EPS 5Y84.42%
EPS Q2Q%21.65%
Revenue 1Y (TTM)17.5%
Revenue growth 3Y18.33%
Revenue growth 5Y20.16%
Sales Q2Q%22.14%

3.2 Future

  • PEN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.81% yearly.
  • Based on estimates for the next years, PEN will show a quite strong growth in Revenue. The Revenue will grow by 13.43% on average per year.
EPS Next Y33.19%
EPS Next 2Y30.32%
EPS Next 3Y28.35%
EPS Next 5Y23.81%
Revenue Next Year14.66%
Revenue Next 2Y14.13%
Revenue Next 3Y13.9%
Revenue Next 5Y13.43%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PEN Yearly Revenue VS EstimatesPEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
PEN Yearly EPS VS EstimatesPEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6 8 10

4

4. PEN Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 87.55 indicates a quite expensive valuation of PEN.
  • Based on the Price/Earnings ratio, PEN is valued a bit cheaper than the industry average as 64.67% of the companies are valued more expensively.
  • PEN is valuated expensively when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
  • PEN is valuated quite expensively with a Price/Forward Earnings ratio of 65.73.
  • Based on the Price/Forward Earnings ratio, PEN is valued a bit cheaper than 65.76% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.84. PEN is valued rather expensively when compared to this.
Industry RankSector Rank
PE 87.55
Fwd PE 65.73
PEN Price Earnings VS Forward Price EarningsPEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PEN is valued a bit cheaper than 64.67% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, PEN is valued a bit cheaper than the industry average as 70.65% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 75.41
EV/EBITDA 59.33
PEN Per share dataPEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PEN does not grow enough to justify the current Price/Earnings ratio.
  • PEN has an outstanding profitability rating, which may justify a higher PE ratio.
  • PEN's earnings are expected to grow with 28.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.64
PEG (5Y)1.04
EPS Next 2Y30.32%
EPS Next 3Y28.35%

0

5. PEN Dividend Analysis

5.1 Amount

  • PEN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

PEN Fundamentals: All Metrics, Ratios and Statistics

PENUMBRA INC

NYSE:PEN (3/13/2026, 8:04:00 PM)

After market: 336.18 0 (0%)

336.18

+1.19 (+0.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-25
Earnings (Next)04-21
Inst Owners95.21%
Inst Owner Change1.37%
Ins Owners2.96%
Ins Owner Change1.82%
Market Cap13.19B
Revenue(TTM)1.40B
Net Income(TTM)177.69M
Analysts69.57
Price Target365.95 (8.86%)
Short Float %4.92%
Short Ratio1.74
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.62%
Min EPS beat(2)4.22%
Max EPS beat(2)5.02%
EPS beat(4)4
Avg EPS beat(4)9.18%
Min EPS beat(4)3.63%
Max EPS beat(4)23.86%
EPS beat(8)8
Avg EPS beat(8)10.88%
EPS beat(12)12
Avg EPS beat(12)25.19%
EPS beat(16)15
Avg EPS beat(16)21.43%
Revenue beat(2)2
Avg Revenue beat(2)3.54%
Min Revenue beat(2)3.05%
Max Revenue beat(2)4.03%
Revenue beat(4)4
Avg Revenue beat(4)2.83%
Min Revenue beat(4)1.67%
Max Revenue beat(4)4.03%
Revenue beat(8)7
Avg Revenue beat(8)1.44%
Revenue beat(12)10
Avg Revenue beat(12)1.44%
Revenue beat(16)12
Avg Revenue beat(16)1.32%
PT rev (1m)0.48%
PT rev (3m)14.61%
EPS NQ rev (1m)-0.18%
EPS NQ rev (3m)-0.32%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)0.29%
Revenue NQ rev (1m)0.2%
Revenue NQ rev (3m)0.3%
Revenue NY rev (1m)0.25%
Revenue NY rev (3m)0.69%
Valuation
Industry RankSector Rank
PE 87.55
Fwd PE 65.73
P/S 9.4
P/FCF 75.41
P/OCF 55.27
P/B 9.24
P/tB 10.51
EV/EBITDA 59.33
EPS(TTM)3.84
EY1.14%
EPS(NY)5.11
Fwd EY1.52%
FCF(TTM)4.46
FCFY1.33%
OCF(TTM)6.08
OCFY1.81%
SpS35.77
BVpS36.38
TBVpS31.97
PEG (NY)2.64
PEG (5Y)1.04
Graham Number56.07
Profitability
Industry RankSector Rank
ROA 9.73%
ROE 12.45%
ROCE 11.52%
ROIC 8.85%
ROICexc 13.24%
ROICexgc 15.72%
OM 13.48%
PM (TTM) 12.66%
GM 67.14%
FCFM 12.46%
ROA(3y)5.5%
ROA(5y)3.35%
ROE(3y)7.13%
ROE(5y)4.35%
ROIC(3y)6.23%
ROIC(5y)4.07%
ROICexc(3y)8.66%
ROICexc(5y)5.61%
ROICexgc(3y)10.48%
ROICexgc(5y)6.87%
ROCE(3y)8.11%
ROCE(5y)5.29%
ROICexgc growth 3Y198.14%
ROICexgc growth 5YN/A
ROICexc growth 3Y208.33%
ROICexc growth 5YN/A
OM growth 3Y165.54%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.05%
GM growth 5Y2.16%
F-Score7
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.13
Debt/EBITDA 0.1
Cap/Depr 364.77%
Cap/Sales 4.54%
Interest Coverage 250
Cash Conversion 115.45%
Profit Quality 98.45%
Current Ratio 6.64
Quick Ratio 4.29
Altman-Z 21.74
F-Score7
WACC10.04%
ROIC/WACC0.88
Cap/Depr(3y)169.98%
Cap/Depr(5y)143.68%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.57%
Profit Quality(3y)413.32%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.8%
EPS 3Y182.68%
EPS 5Y84.42%
EPS Q2Q%21.65%
EPS Next Y33.19%
EPS Next 2Y30.32%
EPS Next 3Y28.35%
EPS Next 5Y23.81%
Revenue 1Y (TTM)17.5%
Revenue growth 3Y18.33%
Revenue growth 5Y20.16%
Sales Q2Q%22.14%
Revenue Next Year14.66%
Revenue Next 2Y14.13%
Revenue Next 3Y13.9%
Revenue Next 5Y13.43%
EBIT growth 1Y58.26%
EBIT growth 3Y214.22%
EBIT growth 5YN/A
EBIT Next Year67.7%
EBIT Next 3Y32.58%
EBIT Next 5Y26.71%
FCF growth 1Y18.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.66%
OCF growth 3YN/A
OCF growth 5YN/A

PENUMBRA INC / PEN FAQ

What is the ChartMill fundamental rating of PENUMBRA INC (PEN) stock?

ChartMill assigns a fundamental rating of 7 / 10 to PEN.


What is the valuation status of PENUMBRA INC (PEN) stock?

ChartMill assigns a valuation rating of 4 / 10 to PENUMBRA INC (PEN). This can be considered as Fairly Valued.


Can you provide the profitability details for PENUMBRA INC?

PENUMBRA INC (PEN) has a profitability rating of 8 / 10.


Can you provide the expected EPS growth for PEN stock?

The Earnings per Share (EPS) of PENUMBRA INC (PEN) is expected to grow by 33.19% in the next year.